IL-33 reduces macrophage foam cell formation
- PMID: 20543107
- DOI: 10.4049/jimmunol.1000520
IL-33 reduces macrophage foam cell formation
Abstract
The development of atherosclerosis, a chronic inflammatory disease characterized by the formation of arterial fibrotic plaques, has been shown to be reduced by IL-33 in vivo. However, whether IL-33 can directly affect macrophage foam cell formation, a key feature of atherosclerotic plaques, has not been determined. In this study, we investigated whether IL-33 reduces macrophage foam cell accumulation in vivo and if IL-33 reduces their formation in vitro using THP-1 and primary human monocyte-derived macrophages. In Apolipoprotein E(-/-) mice fed on a high fat diet, IL-33 treatment significantly reduced the accumulation of macrophage-derived foam cells in atherosclerotic plaques. IL-33 also reduced macrophage foam cell formation in vitro by decreasing acetylated and oxidized low-density lipoprotein uptake, reducing intracellular total and esterified cholesterol content and enhancing cholesterol efflux. These changes were associated with IL-33-mediated reduction in the expression of genes involved in modified low-density lipoprotein uptake, such as CD36, and simultaneous increase in genes involved in cholesterol efflux, including Apolipoprotein E, thereby providing a mechanism for such an action for this cytokine. IL-33 also decreased the expression of key genes implicated in cholesterol esterification and triglyceride storage, including Acyl-CoA:cholesterol acyltransferase 1 and Adipocyte differentiation-related protein. Furthermore, using bone marrow-derived macrophages from ST2(-/-) mice, we demonstrate that the IL-33 receptor, ST2, is integral to the action of IL-33 on macrophage foam cell formation. In conclusion, IL-33 has a protective role in atherosclerosis by reducing macrophage foam cell formation suggesting that IL-33 maybe a potential therapeutic agent against atherosclerosis.
Similar articles
-
Preventive effects of heregulin-beta1 on macrophage foam cell formation and atherosclerosis.Circ Res. 2009 Aug 28;105(5):500-10. doi: 10.1161/CIRCRESAHA.109.193870. Epub 2009 Jul 30. Circ Res. 2009. PMID: 19644050
-
Transient Receptor Potential Ankyrin 1 Channel Involved in Atherosclerosis and Macrophage-Foam Cell Formation.Int J Biol Sci. 2016 May 25;12(7):812-23. doi: 10.7150/ijbs.15229. eCollection 2016. Int J Biol Sci. 2016. PMID: 27313495 Free PMC article.
-
Inhibition of Orai1 Store-Operated Calcium Channel Prevents Foam Cell Formation and Atherosclerosis.Arterioscler Thromb Vasc Biol. 2016 Apr;36(4):618-28. doi: 10.1161/ATVBAHA.116.307344. Epub 2016 Feb 25. Arterioscler Thromb Vasc Biol. 2016. PMID: 26916730
-
Foam cells in atherosclerosis.Clin Chim Acta. 2013 Sep 23;424:245-52. doi: 10.1016/j.cca.2013.06.006. Epub 2013 Jun 16. Clin Chim Acta. 2013. PMID: 23782937 Review.
-
Fluid-phase pinocytosis of LDL by macrophages: a novel target to reduce macrophage cholesterol accumulation in atherosclerotic lesions.Curr Pharm Des. 2013;19(33):5865-72. doi: 10.2174/1381612811319330005. Curr Pharm Des. 2013. PMID: 23438954 Free PMC article. Review.
Cited by
-
Tissue factor is induced by interleukin-33 in human endothelial cells: a new link between coagulation and inflammation.Sci Rep. 2016 May 4;6:25171. doi: 10.1038/srep25171. Sci Rep. 2016. PMID: 27142573 Free PMC article.
-
Cytokines: roles in atherosclerosis disease progression and potential therapeutic targets.Future Med Chem. 2016 Jul;8(11):1317-30. doi: 10.4155/fmc-2016-0072. Epub 2016 Jun 30. Future Med Chem. 2016. PMID: 27357616 Free PMC article. Review.
-
Gentiana scabra Reduces SR-A Expression and Oxidized-LDL Uptake in Human Macrophages.Acta Cardiol Sin. 2016 Jul;32(4):460-6. doi: 10.6515/acs20150416a. Acta Cardiol Sin. 2016. PMID: 27471359 Free PMC article.
-
IL-33 in Atherosclerosis: An Insufficiently Explored and Controversial Research Area.Cardiovasc Drugs Ther. 2024 Jun;38(3):419-420. doi: 10.1007/s10557-024-07553-5. Epub 2024 Jan 31. Cardiovasc Drugs Ther. 2024. PMID: 38294596 No abstract available.
-
Interleukin-33 biology with potential insights into human diseases.Nat Rev Rheumatol. 2011 Jun;7(6):321-9. doi: 10.1038/nrrheum.2011.53. Epub 2011 Apr 26. Nat Rev Rheumatol. 2011. PMID: 21519352 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases